KRAS Mutations: An Old Oncogene Becomes a New Predictive Biomarker

od Riely, Gregory J., Ladanyi, Marc
Wydane 2008

Second Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors In Lung Cancers

od Yu, Helena A., Riely, Gregory J.
Wydane 2013

EGFR: The Paradigm of an Oncogene-Driven Lung Cancer

od Riely, Gregory J., Yu, Helena A.
Wydane w Clin Cancer Res (2015)

Diagnosis and Treatment of ALK Positive NSCLC

od Arbour, Kathryn C., Riely, Gregory J.
Wydane w Hematol Oncol Clin North Am (2017)

Targeting ALK: Precision Medicine Takes On Drug Resistance

od Lin, Jessica J., Riely, Gregory J., Shaw, Alice T.
Wydane w Cancer Discov (2017)

Therapeutic Strategies Utilized in the Setting of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors

od Yu, Helena A., Riely, Gregory J., Lovly, Christine M.
Wydane w Clin Cancer Res (2014)

ALK-rearranged lung cancer: adenosquamous lung cancer masquerading as pure squamous carcinoma

od Chaft, Jamie E., Rekhtman, Natasha, Ladanyi, Marc, Riely, Gregory J.
Wydane 2012

胸腺恶性肿瘤化疗的相关定义和策略

od Girard, Nicolas, Lal, Rohit, Wakelee, Heather, Riely, Gregory J., Loehrer, Patrick J.
Wydane w Zhongguo Fei Ai Za Zhi (2014)

Translating inspiration from COVID-19 vaccine trials to innovations in clinical cancer research

od Choudhury, Noura J., Riely, Gregory J., Sabbatini, Paul J., Hellmann, Matthew D.
Wydane w Cancer Cell (2021)

KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma

od Rekhtman, Natasha, Ang, Daphne C., Riely, Gregory J., Ladanyi, Marc, Moreira, Andre L.
Wydane 2013

Unsuspected collision of synchronous lung adenocarcinomas: a potential cause of aberrant driver mutation profiles

od Rekhtman, Natasha, Borsu, Laetitia, Reva, Boris, Arcila, Maria, Riely, Gregory J., Ladanyi, Marc, Drilon, Alexander
Wydane 2014

Are there imaging characteristics associated with lung adenocarcinomas harboring ALK rearrangements?

od Halpenny, Darragh F., Riely, Gregory J., Hayes, Sara, Yu, Helena, Zheng, Junting, Moskowitz, Chaya S., Ginsberg, Michelle S.
Wydane w Lung Cancer (2014)

Management of thymoma‐associated pure red cell aplasia: A novel use of blood substitute HBOC‐201 in a Jehovah’s Witness

od Rubinstein, Maria M., Goss, Cheryl, Avecilla, Scott T., Dubé, Gregory P., Riely, Gregory J., Mones, Jodi V.
Wydane w Clin Case Rep (2019)

Acquired Resistance to EGFR Kinase Inhibitors Associated with a Novel T854A Mutation in a Patient with EGFR-Mutant Lung Adenocarcinoma

od Bean, James, Riely, Gregory J., Balak, Marissa, Marks, Jenifer L., Ladanyi, Marc, Miller, Vincent A., Pao, William
Wydane 2008

Disease flare after tyrosine kinase inhibitor discontinuation in patients with EGFR-mutant lung cancer and acquired resistance to erlotinib or gefitinib – implications for clinical...

od Chaft, Jamie E., Oxnard, Geoffrey R., Sima, Camelia S., Kris, Mark G., Miller, Vincent A., Riely, Gregory J.
Wydane 2011

A phase 1/2 trial of ruxolitinib and erlotinib in patients with EGFR-mutant lung adenocarcinomas with acquired resistance to erlotinib

od Yu, Helena A., Perez, Leslie, Chang, Qing, Gao, Sizhi P., Kris, Mark G., Riely, Gregory J., Bromberg, Jacqueline
Wydane w J Thorac Oncol (2016)

Basket Trials in Oncology: A Trade-Off Between Complexity and Efficiency

od Cunanan, Kristen M., Gonen, Mithat, Shen, Ronglai, Hyman, David M., Riely, Gregory J., Begg, Colin B., Iasonos, Alexia
Wydane w J Clin Oncol (2017)

Specifying the True- and False-Positive Rates in Basket Trials

od Cunanan, Kristen M., Iasonos, Alexia, Shen, Ronglai, Hyman, David M., Riely, Gregory J., Gönen, Mithat, Begg, Colin B.
Wydane w JCO Precis Oncol (2017)

Lungs don’t forget: Comparison of the KRAS and EGFR mutation profile and survival of “collegiate smokers” and never smokers with advanced lung cancers

od Varghese, Anna M., Sima, Camelia S., Chaft, Jamie E., Johnson, Melissa L., Riely, Gregory J., Ladanyi, Marc, Kris, Mark G.
Wydane 2013

Acquired Resistance of EGFR-Mutant Lung Cancer to a T790M-Specific EGFR Inhibitor: Emergence of a Third Mutation (C797S) in the EGFR Tyrosine Kinase Domain

od Yu, Helena A., Tian, Shaozhou K., Drilon, Alexander E., Borsu, Laetitia, Riely, Gregory J., Arcila, Maria E., Ladanyi, Marc
Wydane w JAMA Oncol (2015)